Table 1.
Clinicopathologic characteristics of papillary thyroid carcinomas (n = 30).
| Clinicopathologic Features | Number (%) |
|---|---|
| Age (years) | 47.6 ± 13.6 a |
| Female sex | 20 (66.7%) |
| Papillary carcinoma | |
| Classic | 24 (80.0%) |
| Tall cell variant | 3 (10.0%) |
| Follicular variant-infiltrative | 1 (3.3%) |
| Follicular variant-encapsulated with capsular invasion | 2 (6.7%) |
| Tumor size (cm) | 1.5 ± 1 a |
| BRAF p.V600E mutation | 20 (66.7%) |
| Lymph node metastasis | 12 (40.0%) |
| ATA (2015) recurrence risk groups | |
| Low risk | 12 (40.0%) |
| Intermediate risk | 18 (60.0%) |
| AJCC stage (8th ed.) | |
| I | 29 (96.7%) |
| II | 1 (3.3%) |
| Other thyroid pathology | |
| Follicular adenoma | 3 (10%) |
| Follicular adenoma, oncocytic | 1 (3.3%) |
| Chronic thyroiditis | 4 (13.3%) |
| Graves-Basedow disease | 1 (3.3%) |
a mean ± standard deviation.